NASDAQ Market News

Agreement “Strengthens Intellectual Property Estate Around TRC102 and Provides Opportunity for Development of Additional Predictive Biomarkers” TRACON Pharmaceuticals (Nasdaq:TCON), a clinical stage biopharmaceutical company focused on the development and commercialization of novel targeted therapeutics for cancer, age-related macular degeneration and fibrotic diseases, announced...

For $134 million Epiq Systems (Nasdaq:EPIQ), a global provider of integrated technology solutions for the legal profession, announced today that the company has signed a definitive agreement to acquire privately-held, Kansas City-based Iris Data Services, the market leading provider of managed services for electronic discovery (eDiscovery). The total consideration for the acquisition is $134...

Who is the new at the top? Endocyte, Inc. (Nasdaq:ECYT) a biopharmaceutical company and leader in developing targeted small molecule drug conjugates (SMDCs) and companion imaging agents for personalized therapy in cancer and other serious diseases, today announced that P. David Mozley, M.D. has been appointed as vice president of imaging. Dr. Mozley will provide […]

Key information below Nanosphere, Inc. (Nasdaq:NSPH), a company enhancing medicine through targeted molecular diagnostics, announced today that a 20-to-1 reverse split of its common stock will be effective at 5:00 p.m. EDT on April 8, 2015, and commencing at the open of trading on Thursday, April 9, 2015, trading of the common stock will continue […]

How will they use the funds? Cellular Biomedicine Group Inc. (Nasdaq:CBMG), a biomedicine firm engaged in the development of effective treatments for degenerative and cancerous diseases, today announced the closing of a private placement transaction under which it sold an aggregate of 515,789 shares of the Company’s common stock, par value $0.001 per share, to […]

Initiation of Fuji’s Phase 2 Trial for 1404 Progenics Pharmaceuticals, Inc. (Nasdaq:PGNX) today announced that its partner, FUJIFILM RI Pharma, has dosed the first patient in its early Phase 2 trial of 1404 in Japan in newly-diagnosed prostate cancer patients with lymph node and/or bone metastases or at high risk for metastatic disease. 1404 is […]

Portfolio Consists of U.S. Distributed Generation Solar Power Plants and 11 Solar Power Plants in the UK TerraForm Power, Inc. (Nasdaq:TERP), a global owner and operator of clean energy power plants, today announced it acquired solar power plants comprising 168 MW from SunEdison, Inc. (NYSE:SUNE) during the first quarter of 2015. All of these power […]

Full Circle Capital Corporation (Nasdaq:FULL) announced today the successful completion of its non-transferable rights offering, which expired on March 30, 2015 as scheduled. The Company received subscriptions for approximately 94% of the shares offered, 17% of which represents commitments by management and Full Circle Advisors. In addition, an institutional investor has committed to purchase...

Nikola Tesla was a genius. He was, arguably, much smarter than his competitor, Thomas Edison. Edison, however was much more shrewd in terms of business acumen. The man who leads the namesake company of Tesla (NASDAQ:TSLA) has the genius of Mr. Tesla and the business acumen of Mr. Edison combined. His name is Elon Musk, […]

++BREAKING NEWS++ Analogic Corporation (Nasdaq:ALOG), enabling the world’s medical imaging and aviation security technology, today announced the resignation of Michael Levitz, senior vice president, chief financial officer and treasurer, effective April 24, 2015. Mr. Levitz has decided to accept the chief financial officer role at Insulet Corporation. Following Mr. Levitz’s...